Our team of highly-qualified professionals has extensive experience across investor relations, equity research, portfolio management, private equity, investment banking, journalism and corporate communications – enabling us to create tailored and remarkably sophisticated solutions for our clients.

Executive Committee

Alan Sheriff

Co-Founder & Co-CEO
Solebury Capital

Alan Sheriff

Alan Sheriff

Co-Founder & Co-CEO
Solebury Capital

Alan Sheriff, a 35-year veteran of the equity capital markets, co-founded Solebury Capital in 2005. Under his guidance and leadership, the firm has become the premier independent equity capital advisory firm, known for bringing deep product expertise, unparalleled market knowledge and unbiased advice to its clients. Alan has personally worked on hundreds of IPOs, follow-ons, block trades and provided general capital markets counsel to financial sponsors such as Bain Capital, Ares Management, Apollo, American Securities, TH Lee, Freeman Spogli, TSG Consumer and many others. He has also worked directly with companies such as Nielson, The Carlyle Group, Dunkin Brands, Canada Goose, BRP (Bombardier Recreational Products), Aramark, Black Knight Financial, Patheon, Planet Fitness, and Party City, among others.

Prior to founding Solebury Capital, Alan held several senior-level positions at Credit Suisse First Boston, including serving as Co-Head of Equity Capital Markets for the Americas. He also chaired Credit Suisse’s Equity Valuation Committee and sat on the firm’s Investment Banking Committee. Alan also led CSFB’s Equity-Linked Capital Markets desk as well as the firm’s ECM Restricted Stock effort. He began his career at Salomon Brothers.

Alan graduated from the University of Rochester with a B.A. in Political Science, Magna Cum Laude, Phi Beta Kappa. He also received a MPA from Columbia University’s School of International and Public Affairs. He is a member of The Council on Foreign Relations and the NationSwell Council.

In January 2011 Alan served as a delegate for the U.S. State Department’s Global Entrepreneurship Program in Egypt, in an effort to promote and spur entrepreneurship around the world. He is also the founder of Teach2Serve, a nonprofit designed to educate and train select high school students for careers in public policy and nonprofit work. Additionally, he is a member of the board of the Travis Manion Foundation, which empowers veterans and families of fallen heroes to develop character in future generations. Alan is also a past Trustee at Delaware Valley University and The Solebury School.

Alan and his wife live in Bucks County, Pennsylvania with their two dogs. They are the proud parents of four sons.

Edward R. Hatfield

Co-Founder & Co-CEO
Solebury Capital

Edward R. Hatfield

Edward R. Hatfield

Co-Founder & Co-CEO
Solebury Capital

Ted Hatfield co-founded Solebury Capital in 2005 and has jointly led the firm to become the country’s most influential equity capital markets advisory boutique. Ted has nearly 30 years of capital markets experience on Wall Street, including a background in fixed income trading, equity underwriting and ECM advisory. Ted has been responsible for the pricing of more than 750 IPOs, marketed follow-ons and block trades in every sector of the economy.

Prior to forming Solebury, Ted spent 20 years at Credit Suisse, serving as Head of U.S. Equity Syndicate Department – Americas. For approximately 10 years, Ted was responsible for overseeing the marketing, pricing, allocation and trading of all Credit Suisse’s equity and equity-linked transactions listed in North America as well as all US-listed transactions marketed abroad. Ted was a member of the organization’s U.S. Equity Management Committee, Global ECM Management Committee, Equity Valuation Committee, Global Research Reform Project Board, IPO Practices Committee and Co-Chairman of the IPO Allocation Review Committee.

Ted received a B.S. in Finance and Marketing from Lehigh University and lives in Summit, NJ with his wife and four children.

Victor Cohn

Chairman and COO
Solebury Capital

Victor Cohn

Chairman and COO
Solebury Capital

Victor has 40 years of financial industry experience. He oversees all administrative and legal matters of Solebury Capital and Solebury Trout, and provides guidance and judgment on the daily business operations of each group.

Victor began his Wall Street career at Salomon Brothers where he was Global Head of Equity Capital Markets. He also served as a member of the four-person Equity Operating Committee, responsible for running Salomon’s global equity business. After Salomon brothers, Victor joined UBS as Co-Head of Investment Banking and Head of North America Capital Markets. He was a member of the Regional Management Committee with responsibility for all U.S. capital markets products. Following UBS, Victor served as Global Head of Equity Capital Markets at Bear Stearns where he was a member of the firm’s Commitment Committee and President’s Council.

Previously, Victor was a member of the Board of Directors at Verity, Inc., chairing both the Audit and Governance committees. Victor was also a member of the Board of Directors at Peregrine Systems, serving as Chairman of the Governance Committee, a member of the Audit Committee and a member of the Special Committee formed to handle the sale of Peregrine. He is a former director of Printcafe Software, Inc., where he also sat on its Audit and Compensation committees as well as the Special Committee of Independent Directors at the time of the company sale. Victor was a director at Dwango Wireless and served as non-executive Chairman.

Victor graduated from Penn State University with a B.S. in Finance and currently lives in Pound Ridge, NY.

Jeff Grossman

Co-Chief Executive Officer
Solebury Trout

Jeff Grossman

Jeff Grossman

Co-Chief Executive Officer
Solebury Trout

Jeff brings nearly 20 years of experience in investor relations and equity capital markets to his role as Co-CEO of Solebury Trout. He leads a team that has delivered strategic investor relations advice and counsel to hundreds of companies across numerous sectors, market caps, and stages in the corporate lifecycle.

Select highlights include:

  • Leading teams in the development and execution of IR activities around hundreds of IPOs and secondary offerings
  • Executing retained investor relations services for companies in the clean tech, alternative energy, industrial and healthcare industries
  • Strategic financial communications projects in conjunction with equity raises, defending against activist shareholder campaigns, leveraged buyouts, M&A transactions, and executive management transitions
  • Development and execution of numerous Investor Days and perception studies

Previously, Jeff was a member of Citi’s Equity Capital Markets team, originating and executing equity capital raises in the industrial and financial sectors. Prior to Citi, Jeff co-founded Ilios Partners LLC, an investor relations and capital markets consulting firm where he led the investment banking services division. He began his career at The Carson Group, in the investor relations consulting field.

Jeff earned his MBA from Columbia Business School and his B.A. in Economics from Tufts University. Jeff is a member of the National Investor Relations Institute (NIRI) and also holds Series 7, 79 and 63 securities licenses.

He lives in Westchester County, NY with his wife and two children.

Leadership

Jonathan Fassberg

Co-Chief Executive Officer

Jonathan Fassberg

Jonathan Fassberg

Co-Chief Executive Officer

Jonathan Fassberg recognized early in his career that small-cap biotechnology companies were underserved in an investor relations capacity. To fill this void, Jonathan founded The Trout Group in 1996 and grew it to become the leading investor relations firm in the life sciences industry. Trout has served over 750 public and private companies both domestically and internationally. In 2017, Trout was acquired by Solebury Communications and the combined firm became known as Solebury Trout.

Highlights of Jonathan’s career include guiding Pharmasset, Pharmacyclics and GW Pharma from inception to IPOs to product launches and ultimate acquisitions. Today Jonathan focuses on client service and outreach to investors in order to build stable shareholder bases for his clients.

Prior to Trout’s founding, Jonathan was a sell-side analyst at a healthcare-focused investment bank. Before his career on Wall Street, Jonathan spent four years at DuPont Pharma in various sales and marketing positions.

Jonathan holds a B.S. in Biology and Chemistry from The University of North Carolina – Chapel Hill and an MBA in finance from New York University’s Stern School of Business. He also holds Series 7, 24, 79 and 63 securities licenses.

Jonathan has been an active member of Young Presidents Organization since joining the Manhattan Chapter in 2007 and is currently serving as Chapter Chair. He also sits on the Board of Directors for the Carolina Center for Jewish Studies at UNC. Jonathan played waterpolo at UNC and for the NYAC after college.

Jonathan lives in New York City and is a doting father to his son and two daughters.

Lisa Wolford

Co-Chief Executive Officer

Lisa Wolford

Lisa Wolford

Co-Chief Executive Officer

Lisa joined Solebury Trout as Co-CEO in September 2017 to lead the corporate communications practice. Lisa brings more than 25 years of experience to the role, having advised CEOs and senior executives at some of the world’s largest and most high-profile companies, as well as innovative start-ups and leading non-profits. Since joining Solebury, select assignments have included:

  • IPO communications strategy for clients as varied as a human capital management technology company; large truck carrier; and innovative biotech firm
  • Presentation and media training courses to prepare senior management teams for analyst days, roadshows, media interviews and other high-profile external speaking opportunities
  • Ongoing communications counsel for retained clients seeking to generate greater external awareness with key stakeholder audiences

Previously, Lisa served as Managing Director, New York for Glover Park Group, a leading public affairs consultancy, where she provided corporate communications counsel across the firm’s client base to companies such as J.P. Morgan Chase and Coca Cola North America. Prior to that, as a Partner at Robinson Lerer Montgomery (now Finsbury), a global corporate and financial communications firm, Lisa led a 20-person team of senior professionals on high-profile, proactive communications programs to support or redefine a company’s image, often for clients undergoing intense media, public and regulatory scrutiny. Large, multi-year engagements included Toyota North America, Citi, UnitedHealth Group and Discover Financial Services.

Lisa has a B.A. in Government from Beloit College. She lives in Brooklyn Heights, NY with her husband and twins, a son and daughter.

Professionals

Bob Ai

Managing Director

Bob Ai

Bob Ai

Managing Director

Bob focuses on Sino-U.S. cross-border banking, strategic consulting services and investor relations. He joined the firm in 2016.

Recent activities include:

  • Arranged and accompanied several trips to China with clients to meet with Chinese strategic and financial investors;
  • Engaged clients on licensing assignment with two completed contracts (vTv’s PDE4 to Newsoara; vTv’s Oral GLP-1 agonist to Huadong Medicine)

Prior to joining the firm, Bob was Managing Director, Senior Biotech Analyst at WallachBeth Capital. Before that, he was the CFO of Aoxing Pharmaceuticals, a NYSE listed Chinese specialty pharmaceutical company. He has also served as Principal in the crossover life science private equity firm Merlin Nexus and was Senior Equity Analyst at asset management firms Bennett Lawrence and Merlin Biomed Group.

Bob received his Ph.D. and MBA degrees from Penn State University and did postdoctoral training at the University of Pennsylvania. He has published eight articles in peer-reviewed scientific journals and also won the prestigious Ray Wu scholarship for outstanding Chinese student to study abroad. Bob holds Series 7, 63, 79, 86, and 87 securities licenses.

Thomas Hoffmann

Managing Director

Thomas Hoffmann

Thomas Hoffmann

Managing Director

Tommy’s knowledge of the European markets and his deep relationships with the European investment community has helped many of Solebury Trout’s clients expand their reach into Europe. Conversely, he also assists clients based outside the United States in navigating the U.S. biotech markets and developing their U.S. investor marketing strategies.

Recent engagement highlights include:

  • Ongoing comprehensive investor relations services including providing counsel on IPOs and financings, developing road shows and implementing strategic plans.
  • Advising on both public and private company financings leading to investments of $400M+.
  • Delivering keynotes and leading several panels before domestic and international CEO and CFO audiences

Tommy co-created Solebury Trout’s annual Hamptons CEO Roundtable and oversees Solebury Trout’s annual Management Access event at the J.P. Morgan Healthcare Conference in San Francisco.

Tommy received an MBA from the University of Augsburg in Germany. He also holds Series 7 and 63 securities licenses.

Brian Korb

Managing Director

Brian Korb

Brian Korb

Managing Director

Brian Korb is a Managing Director based in New York.  Since joining the firm in 2000, Brian has worked with hundreds of companies in the life sciences space, crafting and executing investor relations and communication plans.  He is a trusted advisor who has helped raise over $500M for public and private companies in the U.S. and Europe through private placements, registered directs, convertible debt, royalty transactions, and secondary offerings.

Brian leads efforts around Solebury Trout’s Annual Management Access event during the annual J.P. Morgan Healthcare Conference. He launched the firm’s popular U.S. and EU Wall Street Unplugged Conference series, EU Investor Tour, Pharma BD roundtable as well as the annual Solebury Trout Hamptons CEO Roundtable.

Recent engagements include:

  • Advised a biotech company around their Phase 3 data announcement, conference call and subsequent key opinion leader event at a medical meeting
  • Managed and advised on four 4 private placements for Genfit, a Euronext listed company in France with a Phase 3 trial ongoing in NASH
  • Worked with Vivus and provided investor relations and strategic guidance around FDA Advisory Committee meetings, commercial launch and an activist investor crisis situation

Brian graduated magna cum laude from Tufts University with a B.A. in psychology. He also holds Series 7, 24, 63 and 79 securities licenses.  Brian has also completed more than 10 marathons and is an IRONMAN finisher. He is an active fundraiser for the Leukemia & Lymphoma Society, the Histiocytosis Association and the Achilles Foundation. He is a member of the National Eagle Scout Association. He resides in New York City with his wife and two young children.

Brad Miles

Managing Director

Brad Miles

Brad Miles

Managing Director

Brad Miles is a Managing Director based in New York and leads the firm’s life sciences communications practice. He brings over 20 years of experience leading groundbreaking communications strategies for biopharma companies developing new, advanced approaches to treating diseases.

Prior to joining Solebury Trout in 2018, Brad ran BMC Communications, LLC, a boutique communications firm he started in 1997 focused on advising Life Sciences companies through complex clinical and regulatory milestones as well as financial and M&A transactions.

Recent engagements and highlights include:

  • Led strategy for high profile launch of a new biotech company with $75 million Series A financing round
  • Advised on communications around multi-billion-dollar global partnership agreement
  • Led communications strategy for late-stage clinical data results at a leading medical congress for pharma/biotech collaboration
  • Advised global biopharma company through successful Initial Public Offering on NASDAQ
  • Led corporate repositioning of a leading immuno-oncology company

Prior to founding BMC, Brad spent seven years at the specialized healthcare communications agency Ted Klein & Company (TK&C) in New York City, working with clients including Pfizer, GlaxoSmithKline, Marion Merrell Dow (Sanofi-Aventis), Bristol-Myers Squibb and Cephalon.

Brad received a B.A. in Mass Communications from Grand Valley State University. He lives in the Tribeca neighborhood of New York City with his wife and son.

Michael Levitan

Managing Director

Michael Levitan

Michael Levitan

Managing Director

Michael Levitan is a Managing Director based in New York. Since joining the firm in 2007, Michael has worked on a wide variety of investor relations, financing and M&A advisory engagements. Michael has over 20 years of experience in healthcare investor relations, investment banking and corporate development.

Engagements and representation highlights include:

  • Ongoing investor relations and capital raising advisory with a broad range of biotechnology, pharmaceuticals, diagnostics and medical device companies
  • Advising companies in various fields including oncology, rare disease, Alzheimer’s, microbiome, specialty pharmaceuticals, diabetes, pain, diagnostics and devices
  • Assisting European listed biotechnology companies with their US-focused investor relations and capital raising efforts
  • Advised multiple Nordic based biotechnology companies and organized or held speaking engagements at multiple Nordic focused investor conferences
  • Advised Intendis AG (dermatology division of Bayer Pharmaceuticals) on various acquisition transactions
  • Advised GeneGo (life science IT company) on its sale to Thomson Reuters

Prior to joining The Trout Group, Michael worked for over 10 years as a healthcare investment banker, including at Bear Stearns and Lehman Brothers. Prior to joining Lehman Brothers, Michael worked for Eli Lilly & Company in the business development group. Michael holds an MBA degree in finance and marketing from the University of Chicago Graduate School of Business, and a bachelor of engineering degree in electrical and computer engineering from McGill University. He also holds Series 7, 79 and 63 securities licenses. Michael enjoys skiing, golf, and spending time with his wife and children.

Helen O’Donnell

Managing Director

Helen O’Donnell

Helen O’Donnell

Managing Director

Helen leads investor relations work on initial public offerings, strategic positioning, and earnings presentations and materials for clients in the healthcare and consumer industries.  She also advises her clients on how to effectively communicate significant changes in their industry and their companies to investors. Helen joined the firm in September 2015, after more than 20 years of experience in buy-side and sell-side research.  Examples of recent engagements include:

  • Ongoing representation of a large public contract research organization
  • IPOs of a large outpatient services company and an e-tailer
  • Repositioning the investment case for a health insurance company

Previously, Helen was a senior investment analyst at American Century Investments, a firm with more than $140 billion in assets under management. She covered the global health care sector for the firm’s Global Growth and International Growth Strategies. During her 14 years at American Century, she also followed the consumer sector and co-managed the Global Growth strategy for almost three years.

Earlier in her career, Helen worked on the buy-side as a Senior Vice President and Director of Research for Mitchell Hutchins Asset Management. Before that, Helen was a Senior Vice President in the equity research department of PaineWebber. In that role, she authored detailed industry and company research reports, provided financial models and hosted investment conferences and meetings for clients.

Helen began her career covering medical device companies and healthcare services companies at Smith Barney.

Helen earned a B.A. in Communications from Fordham University.

Chad Rubin

Managing Director

Chad Rubin

Chad Rubin

Managing Director

Chad has more than 18 years of experience in advising life science companies on topics including shareholder targeting, investor roadshows, capital markets transactions, messaging, and scenario analysis.  His experience includes work in finance, consulting and market analysis, helping clients move from creation to follow-on and convertible offerings to M&A/IPO. Chad is involved in capital transactions with corporate clients and has counseled clients on domestic and cross-border transactions, and binary data events.

Recent engagement and representation highlights include:

  • Advised a Phase 2 oncology company on release of clinical data, including KOL support/events, positioning and roadshows with the Wall Street community highlighting the data
  • Managed multiple private offerings for private life sciences and ag biotech companies from series A through series C
  • Managed 50M euro private placement for Genfit, a Euronext listed company with a Phase 3 trial ongoing in NASH
  • Assisted multiple companies through the pre-IPO process including strategy  and support around messaging, materials, investor and analyst roadshows, syndicate selection and organizational support

Prior to joining Solebury Trout in 2005, Chad was the head of the Biotechnology Capital Markets Intelligence Group at Thomson Financial, assisting life sciences companies in their understanding of Wall Street as it pertains to financing transactions, sales and trading dynamics, and perception around clinical and regulatory events.

Chad holds a B.A. in Business Administration with a concentration in Finance from Franklin & Marshall College as well as a minor in Film and Media studies. Chad is a member of the Board of Trustees for the Histiocytosis Association and founder of “All Jacked Up,” an annual event that has raised more than $1M for research and awareness of histiocytic disorders. Chad holds Series 7, 79 and 63 securities licenses.

When not at work, Chad enjoys fishing, gardening, running, cycling, coaching lacrosse and football, playing guitar and hanging out with his family of five.

Lee Stern

Managing Director

Lee Stern

Lee Stern

Managing Director

Lee is a Managing Director at Solebury Trout.  With a broad array of experience in investor relations, management consulting and finance, Lee has worked with numerous health sciences companies to develop and implement their investor positioning strategies, assist them with capital-raising strategies and advise senior management on general company strategy. He joined the firm in 1999.

Recent highlights include:

  • Investor relations support and messaging around capital raises for product-acquisition purposes
  • Transitioning IR function, activity and planning from ex-US to US-centric ahead of NASDAQ IPO
  • Perception study and investor relations audit for top CRO
  • Investor relations strategy and messaging surrounding FDA panel outcome
  • Performing  acquisition  valuation  and  cost  of  capital  analysis  for  a  public, U.S.-based  women’s  health  company acquiring a U.K.-based  formulation  and  manufacturing  provider

Lee holds an MBA from the University of Pennsylvania’s Wharton School and a B.S. in Quantitative Economics from Tufts University.  Lee is also a Chartered Financial Analyst (CFA) and holds Series 7, 24, 79, 63 and 99 securities licenses. He is a member of the CFA Institute, plays drums for a New York-based rock and roll band and enjoys spending free time with his wife, son and daughter.

John Graziano

Senior Vice President

John Graziano

John Graziano

Senior Vice President

John has a depth of experience in investor relations, strategic advisory, management consulting and finance. He has worked with numerous life science and sustainability companies to develop and implement investor relations strategies, increase awareness within the investment community, and support capital raising initiatives. John advises senior management on overall corporate strategy as well as corporate positioning/communications, messaging, roadshow planning and relationship building.  He joined Solebury Trout in 2010 as an intern.

John’s experience includes:

  • Advising multiple companies throughout the IPO process – including syndicate selection, investor targeting, presentation review and management training
  • Assisting in numerous transactions for both private and public companies with over $150M successfully raised
  • Coordinating multiple domestic and international roadshows with high quality institutional investors
  • Expanding the firm’s footprint within the sustainability space working with companies in the ag-biotech and industrial biotech subsectors

Prior to joining the firm, John worked at the Avalon Park and Preserve where he was responsible for the restoration, upkeep and conservation of 140 acres of protected land.

John earned a B.S. in both Applied Economics and Management and Natural Resources from Cornell University. Currently, John is an active board member of the Cornell University College of Agriculture and Life Sciences Alumni Association (CALSAA).  He also holds Series 7, 63 and 79 securities licenses.

In his spare time, John enjoys the great outdoors, lacrosse, working out, snowboarding, and playing guitar.

Joshua Mansbach

Senior Vice President

Joshua Mansbach

Joshua Mansbach

Senior Vice President

Gitanjali Jain Ogawa

Senior Vice President

Gitanjali Jain Ogawa

Gitanjali Jain Ogawa

Senior Vice President

Gita combines her diverse scientific background and knowledge of finance to develop strategic investor relations and communication programs for public and private health sciences companies.  She has extensive experience advising senior management on general company strategy at various stages of the corporate lifecycle. This includes messaging and branding, KOL events, crisis management, and assisting with corporate financings.  She has also built deep relationships with investors, analysts and bankers on the West Coast.  Currently, Gita works on a broad portfolio of companies covering various indications to:

  • Advise around major data announcements and subsequent key opinion leader events at medical meetings
  • Increase institutional ownership and equity research coverage through conducting non-deal roadshows and attending relevant investment focused conferences and medical meetings
  • Maintain and update corporate presentation and messaging to ensure clear and compelling investment thesis as a company evolves
  • Educate all relevant stakeholders on clients’ clinical development plans, financial results, business strategies and other key developments while also obtaining feedback on various aspects of the company

Prior to joining the firm in 2004, Gita worked at Medarex, Inc., a monoclonal antibody-focused company, where she helped create a BCL-2 mouse for optimal monoclonal antibody production.  Prior to that, she was a Research Associate at StemCells, Inc. where she worked in the development of neural markers as they related to monoclonal antibody and protein fragments. During that time, she also co-authored a publication in the Journal of Neuroscience Research.

Gita holds a B.A. in Economics from Brown University and a M.S. in Biology from New York University. Her research while at NYU focused on the effects of catalase on hematopoietic progenitors. She also holds Series 7, 79 and 63 securities licenses.

In her spare time, Gita enjoys playing tennis, hiking, and spending time with her husband and three children.

Jennifer Porcelli

Senior Vice President

Jennifer Porcelli

Jennifer Porcelli

Senior Vice President

Jen Porcelli is a Senior Vice President in the New York office.  Jen works with a broad spectrum of privately-held and publicly-traded life sciences companies throughout various stages of the funding lifecycle; she provides management teams with strategic advice surrounding a variety of investor relations initiatives and conducts targeted outreach to the institutional investor community to identify potential investors and long-term shareholders.  She joined the firm in 2015.

Recent and ongoing assignments include:

  • Advised CNS-focused company around Phase 3 data announcement and subsequent key opinion leader (KOL) event at a medical meeting
  • Planned and coordinated several KOL events and non-deal roadshows for TiGenix NV prior to their acquisition by Takeda Pharmaceutical Co
  • Advised EU-listed Immuno-Oncology company on banker, sell-side analyst, and investor targeting to propel successful private placement to US institutional investors

Prior to joining Solebury Trout, Jen worked on the UBS Investment Bank Corporate Access desk within the Institutional Sales & Trading team, where she spent more than 11 years helping companies across a broad range of sectors with their investor targeting efforts. Prior to that, she worked on the UBS Healthcare Investment Banking team, primarily focused on developing internal & external communications. Jen began her career at JPMorgan on the Investment Bank Marketing team. Jen holds a B.S. in Marketing & Communications from Georgetown University. During her time at Georgetown, Jen worked on Capitol Hill for Senator Tim Johnson (SD) and completed three Marine Corps Marathons.

Jen holds Series 7, 79, and 63 securities licenses.

She enjoys running, rowing, and spending time with her husband and three kids.

Rich Allan

Vice President

Rich Allan

Rich Allan

Vice President

Rich provides communications counsel to multinational biopharmaceutical corporations. He leads communications strategy in connection with late-stage clinical data announcements, company unveilings, partnerships and public awareness initiatives. He has also led message development centered on corporate visibility and differentiation among investor and biopharmaceutical industry audiences. Recent engagements include:

  • Crafting and implementing media strategy around a new therapeutics platform for a 1B+ privately-owned biotech company based in Germany
  • Announcing client data in oral presentations at the 2018 European Hematological Association conference
  • Securing media interest for New York meetings with the chief executive of an international biopharmaceutical company based in Hong Kong and Shanghai
  • Developing a revised messaging platform and corporate presentation with new positioning for a publicly-traded specialty pharmaceutical company in urology and oncology

Prior to joining Solebury Trout, Rich was an executive at Russo Partners, managing corporate communications, investor relations, media engagement and creative project strategy. He has handled announcement strategy and media relations for clients including Cynapsus leading up to its acquisition by Sunovion, as well as leaders in oncology and immuno-oncology announcing major deals with Novartis and Eli Lilly.

Before Russo Partners, Rich was a consultant at Syneos Health, where he specialized in global pharmaceutical product launch, market access and portfolio valuation. He began his career as a researcher in biochemistry, radiation oncology and developmental genetics and is a published co-author in Science and PNAS.

Rich earned an M.Phil in Biochemistry and Biophysics from Columbia University, a M.S. in Biology from New York University, and an A.B. in Molecular Biology from Princeton University.

He lives in Brooklyn, NY, and is a classical cellist.

Julia Balanova

Vice President

Julia Balanova

Julia Balanova

Vice President

Julia works on all aspects of investor relations, and capital-raising challenges and opportunities with a number of biotech and spec pharma companies.  With more than 15 years of experience analyzing and investing in European and US healthcare companies on the buy side, she has a background in clinical research, financial modeling, due diligence, valuation and risk management.  She joined Solebury Trout in 2018.

Her most recent projects include:

  • Working with a hematology oncology company with two late stage assets advising them on all aspects of data presentation and investor communication through the pivotal data readout stage
  • Working with an Asian specialty pharmaceutical company through a midstage development clinical data readout and listing the company on NASDAQ
  • Working with an early stage immune oncology company on the next stage financing

Previously, Julia worked as a healthcare portfolio manager for Schonfeld Strategic Advisors, as well as a fundamental healthcare analyst for a number of hedge funds in NYC.

Julia earned her MS in Applied Math and Finance from Moscow University in Russia.

Mike Biega

Vice President

Mike Biega

Mike Biega

Vice President

Mike Biega is a Vice President in the Boston office. Since joining the firm, Mike has worked closely with clients to help them achieve their investor relations goals and provide them with access to Boston’s investment community. He has experience in strategic messaging, product launches, and corporate positioning. He can often be found on the road, accompanying clients to roadshows, and conferences, as well as meeting with new biotech companies across the therapeutic space.

Recent assignments include:

  • Strategic messaging & positioning for Strongbridge Biopharma and Adamas Pharmaceuticals prior to their launch of their first drug
  • Successfully introducing Wilson Therapeutics to a number of US institutional investors, which lead to a financing with top US Biotech Investors.
  • Organizing many Key Opinion Leader (KOL) and R&D events for clients in Boston, New York and San Francisco
  • Messaging and positioning for three commercial stage clients prior to quarterly earnings

Prior to joining the firm in 2016, Mike worked on the equity sales desk at Summer Street Research Partners, a small boutique investment bank that focused exclusively in life sciences. In that role, his core focus was to develop relationships with institutional investors and speak to them about healthcare research with the goal of helping them make investment decisions.

Mike graduated from Harvard University where he played on the Division I hockey team for four years and graduated with a BA in Economics. He holds the Series 7, 63 and 79 securities licenses. In his spare time, Mike enjoys playing hockey and golf, and fishing.

Amy Bonanno

Vice President

Amy Bonanno

Amy Bonanno

Vice President

Amy Bonanno is a Vice President on the corporate communications team. She is instrumental in managing account teams and developing and executing client campaigns. Over the course of her career, Amy has spearheaded the content creation and production of more than a dozen corporate and disease-awareness websites in addition to videos, animations, photography and scientific illustrations.

Recent work includes:

  • Raising visibility for emerging foreign biopharmas in the U.S. through compelling and cutting-edge written copy, 3-D visuals and original photography
  • Advising companies on corporate and scientific messaging in preparation for pivotal data readouts
  • Conducting corporate communications summit to develop messaging to differentiate client in competitive landscape
  • Developing communications strategy around large acquisition in infectious disease space

Previously, Amy worked at BMC Communications as well as in television news production at CBS News. She also has experience in local television news production, and headed up a public affairs segment for several years as well as produced radio news for local NPR stations. It was her interest in health-related news topics that led to her career in biotech communications.

Amy holds a B.A. in Broadcast Journalism from Syracuse University’s S.I. Newhouse School of Public Communications. She resides in Charleston, SC with her husband. ​

Luke Taylor Brown

Vice President

Luke Taylor Brown

Luke Taylor Brown

Vice President

Luke is a Vice President in the New York office where he provides investor relations and targeting for healthcare companies. He joined Solebury Trout in May of 2018.

Previously, Luke was an accountant at the Bank of New York and worked in the Global Corporate Solutions Group at both Thomson Reuters and NASDAQ, where he provided investor relations consulting. At NASDAQ, he was tasked with wearing multiple hats in getting the advisory business off of the ground when the initiative launched. He worked with the sales team, relationship managers and senior staff to ensure a cohesive message both internally and externally while simultaneously handling client work. Luke also worked as a liaison between the team and the developers to ensure tools were appropriately constructed.

Luke earned his B.S. in Finance from the University of Central Florida and his MBA from The Rollins College Crummer Graduate School of Business. He lives in Brooklyn with his wife and daughter, and is an avid reader and guitarist.

Annie Chang

Vice President

Annie Chang

Annie Chang

Vice President

Annie joined Solebury Trout in 2018 bringing a wide range of experiences in corporate finance, M&A, business development, asset management, and investor relations within high growth industries.

Recent assignments include:

  • Crafting the message, corporate presentation, and investor pitch for private companies raising a first institutional round
  • Situational planning and managing clinical data release for a public biotech company
  • Branding and perception planning for a public biotech company
  • Chinese company business development efforts and alliance with US clinical-stage biotech companies

Prior to joining the firm, she was the Director of Research at Icefield Capital where she helped with the operations of starting a new hedge fund and primarily focused on investments in life science. She has worked in Corporate Development at Yahoo where she worked on corporate strategy and closed on eleven acquisitions. She started her career in finance at Morgan Stanley in Investment Banking working with biotech and gaming companies to support their financing and strategic needs.

Annie has a MBA from INSEAD and a B.S. in Finance from New York University Stern School of Business. In her spare time, she enjoys yoga and spending quality time with family and friends.

Victoria Igumnova

Vice President

Victoria Igumnova

Victoria Igumnova

Vice President

A Vice President with the company since 2009, Victoria is now consulting for Solebury Trout clients on all aspects of Life Sciences investor relations activities.

She assists private and SMid Cap companies with customized IR strategies and plans, including investor and conference targeting, logistics, corporate materials and market due diligence. Victoria provides corporate access to the European investment community with a strong emphasis on perception analysis of companies after non-deal roadshows and industry-related events. Victoria is involved in the day-to-day activities of IR clients and she also advises European companies on fundraising strategies and processes. Victoria also helps with the organization of R&D and Capital Markets days, as well as Solebury Trout events such as educational IR seminars, investor tours and the 1×1 management access event in San Francisco.

Victoria gained experience at several UK-based financial PR and investor relations consultancies. She worked in magazines and newswires in Russia before relocating to London. Victoria graduated with distinction in Journalism from Northern Federal University in Russia and holds a Master of Arts in Public Relations from London College of Communications. Victoria holds the Series 7 securities license. In her spare time she enjoys being with her family, travelling and gardening.

Alan Lada

Vice President

Alan Lada

Alan Lada

Vice President

Alan works with a wide variety of therapeutics clients, supporting them on roadshows and at conferences.  He arranges and staffs Boston-based road shows across Solebury Trout’s client base. He has particularly deep experience working with oncology companies and has supported a number of M&A transactions. He joined the firm in 2014.

Recent assignments include:

  • Four KOL events surrounding data presentations at major medical conferences
  • Messaging and support surrounding the Pfizer / Protalix Elelyso collaboration
  • Messaging and support surrounding the Bayer / Loxo larotrectinib collaboration
  • Targeting, message improvement and strategy for the TCR2 Series B

Previously, Alan worked at Maxim Bank in New York in their Venture Capital division focusing on private biotech companies.  Alan also spent nearly 10 years in the Army National Guard, on both active duty and on reserve status.  He was honorably discharged as a Staff Sergeant.  Alan received his B.A. in Political Science and Government from Rutgers College and has completed graduate courses at Rutgers Business School. He enjoys spending time with friends and relaxing with a book and a good cigar.

Chiara Russo

Vice President

Chiara Russo

Chiara Russo

Vice President

Chiara Russo is a Vice President in the Boston office.  She brings seasoned experience in investor relations having worked with both public and private companies on corporate positioning and message development, scenario/crisis planning, investor targeting and pitching, and general foundational support.

Prior to joining Solebury Trout, Chiara worked for LaVoie Health Science, an integrated communications firm where she advised clients on their communications plans around significant data read-outs, strategized on branding and provided support and guidance through major healthcare conferences.  Before that, Chiara was an equity research analyst for five years, working as a Director at Cantor Fitzgerald and Vice President at Janney Montgomery Scott respectively, covering the Specialty Pharmaceutical sector.

Chiara holds a B.A. in Philosophy from New York University, where she graduated cum laude and a M.B.A. from the F.W. Olin School of Business at Babson College in Wellesley, MA.  She holds Series 7, 63, 86 and 87 securities licenses.

In her spare time, Chiara enjoys a good workout whether that is at the gym or on a long hike, drinking craft beers, cheering on New England sports teams and shoe shopping.

Xuan Yang

Vice President

Xuan Yang

Xuan Yang

Vice President

Xuan Yang is a Vice President in the San Francisco office.  Since joining the firm in 2014, Xuan has executed and delivered on a number of comprehensive investor relations services, strategies, and support to senior management teams in the life sciences sector. He has experience in pre-IPO preparation, IPO execution, corporate messaging and positioning, management changes, and corporate rebranding.

Recent assignments include:

  • CytomX Therapeutics in its pre-IPO preparation and IPO execution
  • BeiGene in its pre-IPO preparation, IPO execution, and corporate messaging, positioning and branding
  • Cascadian Therapeutics in its management change, corporate renaming and rebranding, and analyst day event
  • Advised a biopharma company around its Phase 3 data announcement and commercial launch plans after FDA approval

Prior to joining Solebury Trout, Xuan spent three years in technology investment and merchant banking at Morgan Joseph TriArtisan, where he advised on mergers and acquisitions, executed on private placements, conducted due diligence and performed financial valuation analysis.  In addition, Xuan spent three years in sell-side equity research at Collins Stewart and Canaccord Adams.  He holds Series 7, 63, and 79 securities licenses.

Xuan holds a B.A. in Economics from Vanderbilt University.

Danny Matthews

Senior Associate

Danny Matthews

Danny Matthews

Senior Associate

Danny is a Senior Associate in the New York office. Danny advises early stage clients on private financing rounds, IPOs, and further public transactions, as well as BioPharma companies on how to access public capital markets. His focus areas include pre-IPO market analysis, corporate messaging, as well as scenario analysis. He also possesses experience in the AgBio sector and is part of the business development team at the firm.

Recent assignments include:

  • Adaptimmune’s Series A and subsequent IPO
  • Private placements for Genfit S.A.
  • BioMarin’s acquisition of Prosensa
  • Vericel’s rebranding from Aastrom and follow-on raise

Danny is a recent boomerang to the firm, having left for a couple of years to pursue a venture in the restaurant-tech space.

Danny earned his B.A. with Honors in History at Trinity College. Danny is a born and raised New Yorker and lives in the SoHo neighborhood with his wife Alexa, the founder of @eatingnyc.

Patrick Till

Senior Associate

Patrick Till

Patrick Till

Senior Associate

Patrick joined Solebury Trout in 2014 and delivers strategic advisory and investor relations services to senior management teams across early stage and public companies in the life sciences industry.

Recent assignments include:

  • US and European biotech pre-IPO preparation and execution advisory
  • Orphan drug company Phase 3 data announcement and commercial launch plans
  • Medical technology company new product launch planning, messaging and analyst day event
  • Corporate messaging, management change and financial guidance advisory for a large clinical research organization

Prior to joining Solebury Trout, Patrick worked in the technology transfer industry, commercializing scientific innovations produced from top research institutions in the UK and US. Previously, Patrick worked with a research group in East Africa focused on the epidemiology of infectious diseases.

Patrick earned his BSc in Biological Science and Genomics from the University of Warwick in the UK. In his spare time he enjoys being outdoors, reading books and traveling.

Rebecca John

Associate

Rebecca John

Rebecca John

Associate

Rebecca supports the investor relations team, working with life science clients on corporate strategy, messaging, and IR planning. She currently works with companies across a broad range of development stages in disease spaces including immuno-oncology, gene therapy, and GI. She joined the firm in 2017.

Prior to Solebury Trout, Rebecca interned with the healthcare team at Finn Partners, a New York based communications firm. Additional work experience includes an internship in the Consumer Marketing group at Hearst Magazines, where she worked on digital marketing campaigns across Hearst publications.

Rebecca graduated from Cornell University with a B.A. in Biology and Society. She also holds a Series 7 securities license.

In her free time, Rebecca enjoys running, traveling, and playing violin.

Zara Lockshin

Associate

Zara Lockshin

Zara Lockshin

Associate

Zara is on the life sciences corporate communications team. She specializes in strategy, messaging and media relations.

 

Before joining Solebury Trout, Zara worked as a journalist and television producer in New York covering science, health and human interest.

 

Zara earned an M.S. in journalism from the Columbia University Graduate School of Journalism in 2016. She also holds a B.A. in Philosophy from The Ohio State University and a J.D. from Harvard Law School.

 

Zara is passionate about social media, multimedia storytelling and public health.

 

 

Meggie Purcell

Associate

Meggie Purcell

Meggie Purcell

Associate

Meggie supports the life sciences investor relations team assisting senior management teams with corporate strategy and IR planning.  She currently works with both public and private biotechnology companies throughout all stages of development. Meggie’s experience involves companies across a broad range of disease category, including oncology, CNS, anti-infectives, rare diseases and more. She joined the firm in 2017.

Previously, Meggie held positions performing research at the Hospital for Special Surgery and the Weill-Cornell Medical College, and as a healthcare consultant.

Meggie graduated from Duke University, with a B.S.E. in biomedical engineering, with a concentration in molecular and cellular engineering.  She also holds a Series 7 securities license. In her spare time, Meggie enjoys exploring NYC and watching documentaries.

Stephen Sheriff

Associate

Stephen Sheriff

Stephen Sheriff

Associate

Stephen is a key member of the Solebury Trout team, supporting the senior investor relations team as well as delivering comprehensive investor relations services and support to senior management across the Life Science sector.

Prior to joining Solebury Trout in September 2018, Stephen worked in a senior capacity for Riverhill Ventures, where he helped construct a portfolio of venture start-ups for a family office.  Stephen also owned and operated two health food oriented quick service restaurants.  Prior to his restaurants, Stephen was Associate Head Coach of Men’s and Women’s Tennis at Delaware Valley University. Stephen was a widely recruited four year varsity letter winner/MVP high school tennis player.

Stephen graduated from Delaware Valley University with a B.A. in Psychology.  Stephen was the only student representative on the Cultural Diversity Committee, and was a member of the Presidential Fellows, a select group of students focusing on campus affairs.

In his free time, Stephen enjoys spending time with his wife Stefanie and their menagerie of two dogs, one cat, and a beta fish. His other interests include tennis, basketball, and great restaurants.

Benny Soehngen

Associate

Benny Soehngen

Benny Soehngen

Associate

Benny provides support for events such as the Solebury Trout Management Access Event in San Francisco and the Hamptons CEO Roundtable. He is one of the product developers behind Solebury Trout’s proprietary event management software system and is responsible for data quality and maintenance. He joined the firm in 2014, when he relocated to the US from Germany.

Prior to his transatlantic move, Benny worked for a German national authorized Apple retailer and as a tennis coach for almost ten years. He studied International Business at Aachen University, the largest technology university in Germany and one of the most renowned in Europe, where he focused on marketing and human resources. In addition to English, Benny is fluent in German and French.  In his free time, he enjoys playing soccer, tennis and golf.

Nick Colangelo

Nick Colangelo

Analyst

Nick supports the life sciences investor relations team. He works with both public and private biotechnology companies on corporate strategy and investor relations throughout all stages of development.

Previously, Nick held internship positions with the firm, as well as a summer analyst position for a Healthcare-focused investment banking team at Ladenburg Thalmann.

Nick graduated from the College of the Holy Cross in 2018 with a B.A. in Economics. In his spare time, Nick enjoys playing golf, exploring New York City, and traveling.

Hannah Gendel

Analyst

Julia Deutsch

Julia Deutsch

Analyst

Julia Deutsch supports the life sciences corporate communications team. She conducts competitive research, drafts press releases and develops social media, website and presentation content.

Julia graduated from Cornell University in 2018 with a B.S. in Nutritional Sciences and a minor in Business. Previously, Julia held an internship position at Pfizer and has worked in numerous scientific labs as an undergraduate.

In her spare time, Julia enjoys traveling, exploring New York City and cooking.

Joy Willis

Analyst

Joy Willis

Joy Willis

Analyst

Joy supports the life sciences investor relations team. She works with both public and private biotechnology companies on corporate strategy and investor relations throughout all stages of development.

Joy graduated from Florida State University, studying Environmental Science & Policy with a minor in Biology. Before joining Solebury Trout, she worked as the Environmental Outreach Coordinator at Hester Group, a Federal contracting firm. Previously, she interned internationally at Salzburg Global Seminar, and at the Mayo Clinic of Jacksonville.

In her time off, Joy enjoys soccer, hiking, traveling.

Geoff Gordon

Senior Director of Operations

Geoff Gordon

Geoff Gordon

Senior Director of Operations

Geoff is the firm’s Senior Director of Operations, overseeing all day-to-day enterprise functions of the company, including comprehensive information technology, facilities, and management of the event marketing team.  He joined the firm in 2000, as IT Director.

Prior to joining the firm, Geoff was the Vice President of U.S. Systems for DBRS, Inc., a NRSRO-accredited bond rating agency located in New York City. He was responsible for the New York, Chicago, Virginia, and Texas offices, which had nearly 90 employees. He has also worked externally for many smaller New York businesses on networking, desktop, and helpdesk projects.

Geoff holds a B.A. in American Studies from Tufts University and is a Microsoft Certified Professional and Partner and a Citrix Certified Expert in Virtualization.

Neil Canavan

Scientific Advisor

Neil Canavan

Neil Canavan

Scientific Advisor

Neil is Solebury Trout’s scientific advisor. Since joining the firm four years ago, Neil has provided several forums for clients and investors to interact with life sciences opinion leaders, including:

  • Solebury Trout Talks: An educational seminar series featuring key opinion leaders in the immuno-oncology space. Conducted in a classroom like atmosphere, the Talks give our investors direct one-on-one access to leading clinical investigators.
  • Solebury Trout Podcasts: Offered to clients with truly novel technologies, podcast interviews with client chief scientific officers elucidate, in a conversational manner, the intricacies of a given technology as probed by the moderator. These podcasts are archived in-house, as well as on client websites.
  • Solebury Trout Conference Pre/Post-views. These events are multi-speaker panels that explore upcoming, or recently presented data from major medical meetings. Co-hosted with Bloomberg Intelligence, these invitation-only events offer attendees direct access to the speakers. Recent events have featured top investigators in the cancer immunotherapy field, including Michel Sadelain (Memorial Sloan Kettering), Drew Pardoll (Johns Hopkins), Patrick Ott (Harvard), Carl June (University of Pennsylvania), and many others.

Based on his extensive relationships with industry leaders, Neil recently authored A Cure Within; Scientists Unleashing the Immune System to Kill Cancer, published in the fall of 2017 by Cold Spring Harbor Laboratory press, features 25 of the top investigators in the cancer immunotherapy space. A Cure Within is available on Amazon.

In addition, Neil currently serves as a contributing editor to The Oncology Business Review. Previously, Neil was a global freelance journalist specializing in science and medicine, writing for such news outlets as WebMD, Medscape, The Scientist, and Drug Discovery and Development magazine.

Prior to his career in journalism, Neil has worked as an electrician (New Mexico), deck hand (Mississippi River), roughneck (Gulf of Mexico), cab driver (NYC), and restaurant manager (NYC, World Financial Center).

Neil holds a M.S. in Molecular and Cellular Biodynamics from Rutgers University. In his spare time he enjoys traveling, gardening, mycology, cooking, going to the theater, keeping tropical fish, reading comic books, and playing in a Brooklyn-based pinball league.

Casey Stekloff

Marketing & Events Lead

Casey Stekloff

Casey Stekloff

Marketing & Events Lead

Casey is instrumental in the logistical planning and execution of all life science events for Solebury Trout. She has led the organization of over 20 KOL events, 15 investor & analyst days and five conferences in both the US and abroad. She also heads the logistics of the firm’s largest self-run conference, the annual Solebury Trout Management Access event, which runs in parallel with the JPMorgan Healthcare Conference in San Francisco. Casey manages the meeting rooms and accommodation for 100+ attending clients and projects as well as co-manages the support team during the four-day conference. She joined the firm in 2015.

Prior to joining Solebury Trout, Casey was the Assistant Global Buyer for Nikki Beach Worldwide in Miami and began her career as a sales assistant for an internationally renowned, upscale swimwear brand. Casey graduated from the University of Florida with a B.S. in Advertising and a concentration in Business Administration. In her free time, she loves to travel, read and explore new restaurants in NYC.

Brittany Correia

Creative Services Manager

Brittany Correia

Brittany Correia

Creative Services Manager

Brittany is the Creative Services Manager for Solebury Trout, providing graphic design, developing event materials, and other creative needs for the entirety of the firm. With deep experience and education in graphic design, branding and marketing, Brittany is also the user interface designer behind Solebury Trout’s proprietary Event Management System. She joined the firm in 2016.

Brittany graduated Magna Cum Laude with a B.S. in merchandising from Marist College, where she also studied Global Studies and Business Administration. Previously, Brittany worked as a Human Resources Associate for Dunkin Donuts corporate office and interned in Sales and Visual Merchandising at both Global Brands Group and Haskell Jewels, respectively.

In her free time, Brittany enjoys hiking, traveling and runs a fashion and lifestyle blog.

Courtney Wolfberg

Office Coordinator

Courtney Wolfberg

Courtney Wolfberg

Office Coordinator

Courtney is the Office Coordinator at Solebury Trout and manages the day-to-day organization of the New York office.

Courtney graduated Magna Cum Laude with a B.S in Early Childhood Education from Bloomsburg University.  Previously, Courtney worked as a Preschool teacher in Pennsylvania.

In her free time, Courtney enjoys traveling, thrift shopping and all things fashion.